Ligand Pharmaceuticals (LGND) EPS (Diluted) (2010 - 2026)

Ligand Pharmaceuticals (LGND) EPS (Diluted) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Ligand Pharmaceuticals 6.05 Bn 5.27 Bn 48.45 Mn -0.67

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.67
Dec 31, 2025 2.21
Sep 30, 2025 5.68
Jun 30, 2025 0.24
Mar 31, 2025 -2.21
Dec 31, 2024 -1.70
Mar 31, 2023 -0.09
Dec 31, 2022 -0.17
Sep 30, 2022 -0.54
Jun 30, 2022 -0.80
Mar 31, 2022 -0.15
Dec 31, 2021 -0.13
Sep 30, 2021 -0.39
Jun 30, 2021 -0.33
Mar 31, 2021 -0.27
Dec 31, 2020 1.09
Sep 30, 2020 -0.42
Jun 30, 2020 1.32
Mar 31, 2020 -1.46
Dec 31, 2019 -0.37